Skip to main content

Evaluation 2024 is happening next week! If you’re headed to the conference, check out this preview of Bianka Reese’s presentation.

Reese will be presenting with Mary Hawkins (CHER), Jessica Sperling from the Clinical and Translational Science Institute (CTSI) at Duke University, and Tyler Chisolm from the Clinical and Translational Science Institute (CTSI) at Wake Forest University as part of a multipaper session on Saturday, October 26.

We asked her to share three key points to help folks know before they go. Not heading to Evaluation 2024 this year? Read on for quick takeaways from this Abacus Evaluation project.

What’s the most important takeaway from the work you’re presenting?

The most important takeaway is that aligning Clinical and Translational Science Award (CTSA) activities with the Healthy North Carolina (HNC) 2030 goals is one way to ensure that our state’s clinical research initiatives are grounded in the health priorities of North Carolinians, amplifying community voices and creating measurable impact for translational science activities in key areas like social and economic factors, clinical care and health outcomes.

We worked in collaboration with Duke University and Wake Forest University to summarize the potential human health impacts of our CTSA activities across North Carolina using the HNC 2030 goals as a framework.

What’s a question that you all are still investigating related to the work?

We are still investigating how to effectively capture the long-term impacts of CTSA activities across the state, particularly in areas where alignment with the HNC 2030 indicators is challenging, such as in aligning CTSA activities with HNC 2030 goals like reduced adverse childhood experiences or incarceration rates.

We are working to determine how useful the HNC 2030 goals are for measuring broader public health impacts of translational science activities, guiding project development and for setting funding priorities, even if NC CTSA activities do not fit neatly into the existing framework.

Why should someone attend this session?

Anyone involved in translational research, public health evaluation or community engagement should attend this session to learn how North Carolina CTSAs are integrating statewide public health goals into their evaluation processes.

This session will provide insights into how researchers can align their work with community-driven health priorities and serve as a model for others looking to strengthen the relevance and impact of their translational science projects.

The multipaper session starts Saturday, October 26 at 8:00 a.m.